Rakesh Raman

Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial

Christopher Parker, Noel W. Clarke, Adrian Cook et al. · The Lancet · 2020 · 403 citations · Full text

Medicine, Radiation Oncology, Urology +11

Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial

Chris Parker, Howard Kynaston, Adrian Cook et al. · The Lancet · 2024 · 72 citations · Full text

Medicine, Oncology, Urology +15

Abstract PR014: Preliminary safety and anti-tumor activity of RMC-6291, a first-in-class, tri-complex KRASG12C(ON) inhibitor, in patients with or without prior KRASG12C(OFF) inhibitor treatment

Pasi A. Jänne, Frédéric Bigot, Kyriakos P. Papadopoulos et al. · Molecular Cancer Therapeutics · 2023 · 56 citations

Medicine, Oncology, Pharmacology +15

Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047)

Chris Parker, Adrian Cook, Noel W. Clarke et al. · Annals of Oncology · 2024 · 49 citations · Full text

Medicine, Radiation Oncology, Surgery +17

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

Chris Parker, Noel W. Clarke, Adrian Cook et al. · The Lancet · 2024 · 49 citations · Full text

Medicine, Oncology, Surgery +15